Enovis (ENOV) Non-Current Assets (2010 - 2026)
Enovis' (ENOV) quarterly Non-Current Assets came in at $2.6 billion in Q3 2026, down 31.8% year-over-year from $3.7 billion in Q3 2025, and down 1.59% quarter-over-quarter from $2.6 billion in Q2 2026.
Analysis
Enovis (ENOV) Non-Current Assets (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Non-Current Assets for 17 consecutive years, with $2.6 billion the latest figure, recorded in Q3 2026.
- On a quarterly basis, Non-Current Assets fell 31.8% year-over-year to $2.6 billion in Q3 2026; TTM through Jul 2026 was $10.9 billion, a 28.68% decrease from a year earlier, with the FY2025 full-year figure at $2.6 billion, down 26.44% from the prior year.
- Non-Current Assets was $2.6 billion for Q3 2026 at Enovis, down from $2.6 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $6.1 billion in Q2 2022 and troughed at $2.6 billion in Q3 2026.
- A 5-year average of $3.6 billion and a median of $3.6 billion in 2023 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets tumbled 44.98% in 2022 and advanced 24.85% in 2024, its largest moves.
- Over 5 years, Non-Current Assets stood at $3.5 billion in 2022, then grew by 3.87% to $3.6 billion in 2023, then decreased by 1.12% to $3.6 billion in 2024, then slipped by 26.44% to $2.6 billion in 2025, then slipped by 2.9% to $2.6 billion in 2026.
- The last three Non-Current Assets figures came in at $2.6 billion (Q3 2026), $2.6 billion (Q2 2026), and $2.6 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.92 Bn | 176.31 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.92 Bn | 109.10 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 105.39 Bn | 101.91 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 64.88 Bn | 64.34 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.24 Bn | 31.79 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.12 Bn | 30.18 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Enovis | 1.08 Bn | 1.06 Bn | 359.25 Mn | 2.55 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 2.55 Bn |
| Apr 3, 2026 | 2.59 Bn |
| Dec 31, 2025 | 2.63 Bn |
| Oct 3, 2025 | 3.15 Bn |
| Jul 4, 2025 | 3.74 Bn |
| Apr 4, 2025 | 3.66 Bn |
| Dec 31, 2024 | 3.57 Bn |
| Sep 27, 2024 | 4.35 Bn |
| Jun 28, 2024 | 4.27 Bn |
| Mar 29, 2024 | 4.33 Bn |
| Dec 31, 2023 | 3.61 Bn |
| Sep 29, 2023 | 3.55 Bn |
| Jun 30, 2023 | 3.56 Bn |
| Mar 31, 2023 | 3.47 Bn |
| Dec 31, 2022 | 3.48 Bn |
| Sep 30, 2022 | 3.44 Bn |
| Jul 1, 2022 | 3.43 Bn |
| Apr 1, 2022 | 6.14 Bn |
| Dec 31, 2021 | 6.21 Bn |
| Oct 1, 2021 | 6.25 Bn |